BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, Bridle KR, Doecke JD, Meikle PJ, Turlin B. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology. 2009;49:533-544. [PMID: 19115220 DOI: 10.1002/hep.22637] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Sahin H, Trautwein C, Wasmuth HE. Functional role of chemokines in liver disease models. Nat Rev Gastroenterol Hepatol 2010;7:682-90. [DOI: 10.1038/nrgastro.2010.168] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
2 Rau M, Baur K, Geier A. Host genetic variants in the pathogenesis of hepatitis C. Viruses 2012;4:3281-302. [PMID: 23342360 DOI: 10.3390/v4123281] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
3 Köhn-Gaone J, Gogoi-Tiwari J, Ramm GA, Olynyk JK, Tirnitz-Parker JE. The role of liver progenitor cells during liver regeneration, fibrogenesis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2016;310:G143-54. [PMID: 26608186 DOI: 10.1152/ajpgi.00215.2015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
4 He X, Pu G, Tang R, Zhang D, Pan W. Activation of nuclear factor kappa B in the hepatic stellate cells of mice with schistosomiasis japonica. PLoS One 2014;9:e104323. [PMID: 25116007 DOI: 10.1371/journal.pone.0104323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
5 Loo CK, Pereira TN, Ramm GA. Abnormal WT1 expression in human fetuses with bilateral renal agenesis and cardiac malformations. Birth Defects Res A Clin Mol Teratol 2012;94:116-22. [PMID: 22246978 DOI: 10.1002/bdra.22881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Gillespie CD, O'Reilly MK, Allen GN, McDermott S, Chan VO, Ridge CA. Imaging the Abdominal Manifestations of Cystic Fibrosis. Int J Hepatol 2017;2017:5128760. [PMID: 28250993 DOI: 10.1155/2017/5128760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
7 Wen M, Liu Y, Chen R, He P, Wu F, Li R, Lin Y. Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis. Phytother Res 2021;35:3799-811. [PMID: 33763888 DOI: 10.1002/ptr.7086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Stieger B, Geier A. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. Expert Opin Drug Metab Toxicol 2011;7:411-25. [PMID: 21320040 DOI: 10.1517/17425255.2011.557067] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
9 Dwyer BJ, Olynyk JK, Ramm GA, Tirnitz-Parker JE. TWEAK and LTβ Signaling during Chronic Liver Disease. Front Immunol 2014;5:39. [PMID: 24592262 DOI: 10.3389/fimmu.2014.00039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
10 Kim YJ, Choi MS, Park YB, Kim SR, Lee MK, Jung UJ. Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. World J Gastroenterol 2013; 19(29): 4689-4701 [PMID: 23922466 DOI: 10.3748/wjg.v19.i29.4689] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
11 Inoue T, Kawaji T, Tanihara H. Monocyte chemotactic protein-1 level in the aqueous humour as a prognostic factor for the outcome of trabeculectomy. Clin Exp Ophthalmol 2014;42:334-41. [PMID: 24025148 DOI: 10.1111/ceo.12204] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
12 Xu W, Zeng S, Li M, Fan Z, Zhou B. Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription. J Biomed Res 2017;31:428-36. [PMID: 28958996 DOI: 10.7555/JBR.30.20160046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Ghazanfari T, Yaraee R, Kariminia A, Ebtekar M, Faghihzadeh S, Vaez-mahdavi MR, Rezaei A, Vojgani M, Soroush MR, Kermani-jalilvand A, Mohammadi P, Foroutan A, Hassan ZM. Alterations in the serum levels of chemokines 20years after sulfur mustard exposure: Sardasht-Iran Cohort Study. International Immunopharmacology 2009;9:1471-6. [DOI: 10.1016/j.intimp.2009.08.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
14 Lewindon PJ, Shepherd RW, Walsh MJ, Greer RM, Williamson R, Pereira TN, Frawley K, Bell SC, Smith JL, Ramm GA. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011;53:193-201. [DOI: 10.1002/hep.24014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
15 Loo CK, Pereira TN, Ramsing M, Vogel I, Petersen OB, Ramm GA. Mechanism of pancreatic and liver malformations in human fetuses with short-rib polydactyly syndrome. Birth Defects Res A Clin Mol Teratol 2016;106:549-62. [PMID: 26970085 DOI: 10.1002/bdra.23495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. Biofactors. 2013;39:88-100. [PMID: 23303639 DOI: 10.1002/biof.1057] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
17 Ledder O, Haller W, Couper RT, Lewindon P, Oliver M. Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. J Gastroenterol Hepatol 2014;29:1954-62. [PMID: 25238538 DOI: 10.1111/jgh.12785] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
18 Park KC, Park JH, Jeon JY, Kim SY, Kim JM, Lim CY, Lee TH, Kim HK, Lee HG, Kim SM, Kwon HJ, Suh JS, Kim SW, Choi SH. A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells. Br J Pharmacol 2014;171:4820-30. [PMID: 24467283 DOI: 10.1111/bph.12590] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
19 Wood MJ, Powell LW, Dixon JL, Subramaniam VN, Ramm GA. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol 2013; 19(48): 9366-9376 [PMID: 24409064 DOI: 10.3748/wjg.v19.i48.9366] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Ludwig JM, Zhang Y, Chamulitrat W, Stremmel W, Pathil A. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury. PLoS One. 2018;13:e0197836. [PMID: 29795632 DOI: 10.1371/journal.pone.0197836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009;50:185-197. [PMID: 19441102 DOI: 10.1002/hep.22952] [Cited by in Crossref: 273] [Cited by in F6Publishing: 264] [Article Influence: 21.0] [Reference Citation Analysis]
22 Anthony BJ, James KR, Gobert GN, Ramm GA, McManus DP. Schistosomajaponicum Eggs Induce a Proinflammatory, Anti-Fibrogenic Phenotype in Hepatic Stellate Cells. PLoS One 2013;8:e68479. [PMID: 23840855 DOI: 10.1371/journal.pone.0068479] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
23 Calvopina DA, Chatfield MD, Weis A, Coleman MA, Fernandez-rojo MA, Noble C, Ramm LE, Leung DH, Lewindon PJ, Ramm GA. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis: Hepatology. Hepatology 2018;68:2301-16. [DOI: 10.1002/hep.30156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
24 Burke ML, McManus DP, Ramm GA, Duke M, Li Y, Jones MK, Gobert GN. Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis 2010;4:e598. [PMID: 20161726 DOI: 10.1371/journal.pntd.0000598] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
25 Enache EL, Sin A, Enache LS, Bancu L. Triplex High-Resolution Melting Assay for the Simultaneous Assessment of IFNL3 rs12979860, ABCB11 rs2287622, and RNF7 rs16851720 Genotypes in Chronic Hepatitis C Patients. J Mol Diagn 2017;19:857-69. [PMID: 28860020 DOI: 10.1016/j.jmoldx.2017.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Tang YM, Wang JP, Bao WM, Yang JH, Ma LK, Yang J, Chen H, Xu Y, Yang LH, Li W. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. Int J Mol Med. 2015;36:377-385. [PMID: 26046127 DOI: 10.3892/ijmm.2015.2233] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
27 Garcia AM, Dorsey J. Nonpulmonary Manifestations of Cystic Fibrosis. Kendig's Disorders of the Respiratory Tract in Children. Elsevier; 2019. pp. 788-799.e3. [DOI: 10.1016/b978-0-323-44887-1.00052-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Cummins CB, Wang X, Xu J, Hughes BD, Ding Y, Chen H, Zhou J, Radhakrishnan RS. Antifibrosis Effect of Novel Oridonin Analog CYD0618 Via Suppression of the NF-κB Pathway. J Surg Res 2018;232:283-92. [PMID: 30463731 DOI: 10.1016/j.jss.2018.06.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
29 Cummins CB, Wang X, Nunez Lopez O, Graham G, Tie HY, Zhou J, Radhakrishnan RS. Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway. Int J Mol Sci 2018;19:E1567. [PMID: 29795016 DOI: 10.3390/ijms19061567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
30 Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. CCR2 promotes hepatic fibrosis in mice. Hepatology. 2009;50:185-197. [PMID: 19441102 DOI: 10.1002/hep.22952.ccr2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Mortensen HM, Reif DM, Rotroff DM, Shah I, Richard AM, Dix DJ. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ Health Perspect 2010;118:485-92. [PMID: 20368123 DOI: 10.1289/ehp.0901392] [Cited by in Crossref: 389] [Cited by in F6Publishing: 340] [Article Influence: 32.4] [Reference Citation Analysis]
32 Tu T, Calabro SR, Lee A, Maczurek AE, Budzinska MA, Warner FJ, McLennan SV, Shackel NA. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis? J Gastroenterol Hepatol. 2015;30:1696-1704. [PMID: 26239824 DOI: 10.1111/jgh.13065] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
33 Pereira TN, Lewindon PJ, Greer RM, Hoskins AC, Williamson RM, Shepherd RW, Ramm GA. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr 2012;54:328-35. [PMID: 22157922 DOI: 10.1097/MPG.0b013e3182432034] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
34 Syal G, Fausther M, Dranoff JA. Advances in cholangiocyte immunobiology. Am J Physiol Gastrointest Liver Physiol 2012;303:G1077-86. [PMID: 22961800 DOI: 10.1152/ajpgi.00227.2012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
35 Lages CS, Simmons J, Maddox A, Jones K, Karns R, Sheridan R, Shanmukhappa SK, Mohanty S, Kofron M, Russo P, Wang YH, Chougnet C, Miethke AG. The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia. Hepatology 2017;65:174-88. [PMID: 27641439 DOI: 10.1002/hep.28851] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
36 Pozniak KN, Pearen MA, Pereira TN, Kramer CSM, Kalita-De Croft P, Nawaratna SK, Fernandez-Rojo MA, Gobert GN, Tirnitz-Parker JEE, Olynyk JK, Shepherd RW, Lewindon PJ, Ramm GA. Taurocholate Induces Biliary Differentiation of Liver Progenitor Cells Causing Hepatic Stellate Cell Chemotaxis in the Ductular Reaction: Role in Pediatric Cystic Fibrosis Liver Disease. Am J Pathol. 2017;187:2744-2757. [PMID: 28935574 DOI: 10.1016/j.ajpath.2017.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
37 Aller MA, Arias JL, Prieto I, Losada M, Arias J. Bile duct ligation: step-by-step to cholangiocyte inflammatory tumorigenesis. Eur J Gastroenterol Hepatol 2010;22:651-61. [PMID: 19641467 DOI: 10.1097/MEG.0b013e32832e0a2f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
38 Pereira TN, Walsh MJ, Lewindon PJ, Ramm GA. Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis. World J Gastrointest Pathophysiol 2010; 1(2): 69-84 [PMID: 21607144 DOI: 10.4291/wjgp.v1.i2.69] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
39 Leeuwen L, Fitzgerald DA, Gaskin KJ. Liver disease in cystic fibrosis. Paediatr Respir Rev. 2013;Jun 13; Epub ahead of print. [PMID: 23769887 DOI: 10.1016/j.prrv.2013.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bohanon FJ, Wang X, Graham BM, Prasai A, Vasudevan SJ, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J, Radhakrishnan RS. Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells. Mol Cell Biochem 2015;410:293-300. [PMID: 26346163 DOI: 10.1007/s11010-015-2562-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
41 Invernizzi P. Hunting for fibrosis progression genes in hepatitis C patients. Clin Sci (Lond) 2011;120:285-6. [PMID: 21087209 DOI: 10.1042/CS20100553] [Reference Citation Analysis]
42 Nadler EP, Li X, Onyedika E, Greco MA. Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia. J Surg Res 2010;159:611-7. [PMID: 20097372 DOI: 10.1016/j.jss.2009.10.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
43 Sahin H, Berres M, Wasmuth HE. Therapeutic potential of chemokine receptor antagonists for liver disease. Expert Review of Clinical Pharmacology 2014;4:503-13. [DOI: 10.1586/ecp.11.24] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Wang L, Luo Q, Zeng S, Lou Y, Li X, Hu M, Lu L, Liu Z. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice. J Pathol 2021. [PMID: 34410012 DOI: 10.1002/path.5780] [Reference Citation Analysis]
45 Fratta LXS, Hoss GRW, Longo L, Uribe-cruz C, da Silveira TR, Vieira SMG, Kieling CO, dos Santos JL. Hypoxic-ischemic gene expression profile in the isolated variant of biliary atresia. J Hepatobiliary Pancreat Sci 2015;22:846-54. [DOI: 10.1002/jhbp.297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
46 Zhao H, Han Q, Lu N, Xu D, Tian Z, Zhang J. HMBOX1 in hepatocytes attenuates LPS/D-GalN-induced liver injury by inhibiting macrophage infiltration and activation. Mol Immunol. 2018;101:303-311. [PMID: 30032072 DOI: 10.1016/j.molimm.2018.07.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
47 Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM, Daniluk U, Sobaniec P, Sendrowski K, Daniluk J, Reszec J, Debek W. Ultrastructural Characteristics of Rat Hepatic Oval Cells and Their Intercellular Contacts in the Model of Biliary Fibrosis: New Insights into Experimental Liver Fibrogenesis. Gastroenterol Res Pract 2017;2017:2721547. [PMID: 28769978 DOI: 10.1155/2017/2721547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
48 Zhou K, Lin N, Xiao Y, Wang Y, Wen J, Zou GM, Gu X, Cai W. Elevated bile acids in newborns with Biliary Atresia (BA). PLoS One 2012;7:e49270. [PMID: 23166626 DOI: 10.1371/journal.pone.0049270] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
49 Ramm GA. Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease. Hepatology. 2009;50:1664-1668. [PMID: 19877298 DOI: 10.1002/hep.23338] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
50 Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond). 2011;120:287-296. [PMID: 20883210 DOI: 10.1042/cs20100246] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
51 Giordano DM, Pinto C, Maroni L, Benedetti A, Marzioni M. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies. Int J Mol Sci 2018;19:E3003. [PMID: 30275402 DOI: 10.3390/ijms19103003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
52 Tirnitz-Parker JE, Olynyk JK, Ramm GA. Role of TWEAK in co-regulating liver progenitor cell and fibrogenic responses. Hepatology. 2013; Aug 26. [Epub ahead of print]. [PMID: 24038142 DOI: 10.1002/hep.26701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
53 Sommerhalder C, Cummins CB, Wang X, Ramdas D, Lopez ON, Gu Y, Zhou J, Radhakrishnan RS. HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways. J Surg Res 2021;261:334-42. [PMID: 33486415 DOI: 10.1016/j.jss.2020.12.045] [Reference Citation Analysis]
54 Wang ZM, Chen YJ. Recent progress in understanding pathogenesis and liver pathology in biliary atresia. Shijie Huaren Xiaohua Zazhi 2012; 20(27): 2576-2582 [DOI: 10.11569/wcjd.v20.i27.2576] [Reference Citation Analysis]
55 Paumgartner G. Pharmacotherapy of cholestatic liver diseases: Therapy of cholestatic liver diseases. Journal of Digestive Diseases 2010;11:119-25. [DOI: 10.1111/j.1751-2980.2010.00427.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
56 Kassel KM, Guo GL, Tawfik O, Luyendyk JP. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet. Lab Invest. 2010;90:1794-1804. [PMID: 20697377 DOI: 10.1038/labinvest.2010.143] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
57 Zhang Y, Huang D, Gao W, Yan J, Zhou W, Hou X, Liu M, Ren C, Wang S, Shen J. Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica. Int Immunol. 2015;27:317-325. [PMID: 25840437 DOI: 10.1093/intimm/dxv017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
58 Lemaitre C, Dominique S, Billoud E, Eliezer M, Montialoux H, Quillard M, Riachi G, Koning E, Morisse-Pradier H, Savoye G. Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? Can Respir J. 2016;2016:4592702. [PMID: 27445541 DOI: 10.1155/2016/4592702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
59 Loo CK, Pearen MA, Pereira TN, Perry-keene J, Payton D, Ramm GA. Lung and liver growth and retinoic acid status in human fetuses with congenital diaphragmatic hernia. Early Human Development 2018;116:17-23. [DOI: 10.1016/j.earlhumdev.2017.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
60 Wang FS, Zhang Z. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol. 2009;3:499-512. [PMID: 19817672 DOI: 10.1586/egh.09.50] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
61 Desmet VJ. Ductal plates in hepatic ductular reactions. Hypothesis and implications. II. Ontogenic liver growth in childhood. Virchows Arch. 2011;458:261-270. [PMID: 21298286 DOI: 10.1007/s00428-011-1049-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
62 Hua X, Shan Y, Li D, Xu D, Zhang J, Yang T, Han L, Shen C, Xia Y, Chen Q, Ma X, Zhang J, Xia Q. A Potential Profibrogenic Role of Biliary Epithelium-Derived Cardiotrophin-1 in Pediatric Cholestatic Liver Disease. J Interferon Cytokine Res 2015;35:606-12. [PMID: 25919795 DOI: 10.1089/jir.2014.0128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
63 Zhang JB, Zhang B, Guo L, Lin ZH, Li XQ, Guo K, Sun HC, Ye QH. Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma. Oncotarget 2015;6:40223-34. [PMID: 26474280 DOI: 10.18632/oncotarget.5540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
64 Friedman SL. Hepatic Fibrosis. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 295-315. [DOI: 10.1002/9781119950509.ch12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells. Trends Parasitol 2018;34:524-40. [PMID: 29526403 DOI: 10.1016/j.pt.2018.02.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
66 Miethke AG, Zhang W, Simmons J, Taylor AE, Shi T, Shanmukhappa SK, Karns R, White S, Jegga AG, Lages CS, Nkinin S, Keller BT, Setchell KD. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice. Hepatology. 2016;63:512-523. [PMID: 26172874 DOI: 10.1002/hep.27973] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 11.1] [Reference Citation Analysis]
67 Noetel A, Elfimova N, Altmüller J, Becker C, Becker D, Lahr W, Nürnberg P, Wasmuth H, Teufel A, Büttner R. Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells. J Hepatol. 2013;58:335-341. [PMID: 23041308 DOI: 10.1016/j.jhep.2012.09.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
68 Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30:141-150. [PMID: 24433721 DOI: 10.1016/j.pt.2013.12.009] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 13.1] [Reference Citation Analysis]
69 Hua X, Lu T, Zhang J, Miao Q, Bian Z, Zhang H, Huang S, Lin W, Xi Z, Zhang M, Chen Q, Ma X, Zhang J, Xia Q. Hypoxia-inducible factor-2α promotes hepatocyte apoptosis during cholestasis. Hepatol Res 2017;47:95-102. [PMID: 26992434 DOI: 10.1111/hepr.12708] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Loo CK, Pereira TN, Pozniak KN, Ramsing M, Vogel I, Ramm GA. The development of hepatic stellate cells in normal and abnormal human fetuses - an immunohistochemical study. Physiol Rep 2015;3:e12504. [PMID: 26265759 DOI: 10.14814/phy2.12504] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Liu Z, Zhang Z, Huang M, Sun X, Liu B, Guo Q, Chang Q, Duan Z. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments. BMC Gastroenterol 2018;18:112. [PMID: 29996772 DOI: 10.1186/s12876-018-0842-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
72 Olivier AK, Gibson-Corley KN, Meyerholz DK. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. Am J Physiol Gastrointest Liver Physiol 2015;308:G459-71. [PMID: 25591863 DOI: 10.1152/ajpgi.00146.2014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
73 Mitchell C, Mahrouf-Yorgov M, Mayeuf A, Robin MA, Mansouri A, Fromenty B, Gilgenkrantz H. Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease. Lab Invest. 2011;91:273-282. [PMID: 20856227 DOI: 10.1038/labinvest.2010.163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
74 Sun J, Wang J, Zhang N, Yang R, Chen K, Kong D. Identification of global mRNA expression profiles and comprehensive bioinformatic analyses of abnormally expressed genes in cholestatic liver disease. Gene 2019;707:9-21. [PMID: 31048068 DOI: 10.1016/j.gene.2019.04.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA. Circulating MicroRNAs as Noninvasive Diagnostic Biomarkers of Liver Disease in Children With Cystic Fibrosis. Journal of Pediatric Gastroenterology & Nutrition 2015;60:247-54. [DOI: 10.1097/mpg.0000000000000600] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
76 Besheer T, Arafa M, El-Maksoud MA, Elalfy H, Hasson A, Zalata K, Elkashef W, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, Zaghloul H, Razek AA, El-Bendary M. Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels. Turk J Gastroenterol 2018;29:299-307. [PMID: 29755014 DOI: 10.5152/tjg.2018.17570] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
77 Bohanon FJ, Wang X, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J, Radhakrishnan RS. Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res 2014;190:55-63. [PMID: 24742622 DOI: 10.1016/j.jss.2014.03.036] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
78 Debray D, Corvol H, Housset C. Modifier genes in cystic fibrosis-related liver disease. Curr Opin Gastroenterol 2019;35:88-92. [PMID: 30585791 DOI: 10.1097/MOG.0000000000000508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]